Ljungberg B - Search Results

1

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.

Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. Ljungberg B, et al. Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. Eur Urol. 2022. PMID: 35346519 Free article.

2

Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters.

Hedberg Y, Roos G, Ljungberg B, Landberg G. Hedberg Y, et al. Among authors: ljungberg b. Acta Oncol. 2002;41(2):175-81. doi: 10.1080/028418602753669562. Acta Oncol. 2002. PMID: 12102163

3

Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.

Ljungberg B, Jacobsen J, Häggström-Rudolfssson S, Rasmuson T, Lindh G, Grankvist K. Ljungberg B, et al. Urol Res. 2003 Oct;31(5):335-40. doi: 10.1007/s00240-003-0346-x. Epub 2003 Sep 13. Urol Res. 2003. PMID: 14574539

4

Prognostic factors in renal cell carcinoma.

Ljungberg B. Ljungberg B. Urologe A. 2004 Sep;43 Suppl 3:S119-20. doi: 10.1007/s00120-004-0594-6. Urologe A. 2004. PMID: 15179550 No abstract available.

5

The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B. Lidgren A, et al. Among authors: ljungberg b. Clin Cancer Res. 2005 Feb 1;11(3):1129-35. Clin Cancer Res. 2005. PMID: 15709180

6

Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.

Papworth K, Grankvist K, Ljungberg B, Rasmuson T. Papworth K, et al. Among authors: ljungberg b. Tumour Biol. 2005 Jul-Aug;26(4):201-6. doi: 10.1159/000086953. Epub 2005 Jul 7. Tumour Biol. 2005. PMID: 16006777

7

Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.

Alamdari FI, Ljungberg B. Alamdari FI, et al. Among authors: ljungberg b. Scand J Urol Nephrol. 2005;39(4):277-82. doi: 10.1080/003655905100077775. Scand J Urol Nephrol. 2005. PMID: 16118103

8

Endoglin (CD105) expression in human renal cell carcinoma.

Sandlund J, Hedberg Y, Bergh A, Grankvist K, Ljungberg B, Rasmuson T. Sandlund J, et al. Among authors: ljungberg b. BJU Int. 2006 Apr;97(4):706-10. doi: 10.1111/j.1464-410X.2006.06006.x. BJU Int. 2006. PMID: 16536758

9

Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma.

Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B. Jacobsen J, et al. Among authors: ljungberg b. BJU Int. 2006 May;97(5):1102-8. doi: 10.1111/j.1464-410X.2006.06138.x. BJU Int. 2006. PMID: 16643499

10

Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B. Lidgren A, et al. Among authors: ljungberg b. Eur Urol. 2006 Dec;50(6):1272-7. doi: 10.1016/j.eururo.2006.05.043. Epub 2006 Jun 13. Eur Urol. 2006. PMID: 16814458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters